Stock listing

4AB Stock Price, News, Filings & Events — Abbvie Inc.

Selected listing: 4AB · TRADEGATE · EUR · DE

This page tracks Abbvie Inc.'s 4AB:TRADEGATE listing on TRADEGATE in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 4AB:TRADEGATE. 4AB:TRADEGATE is the stock-level entry point for investors researching Abbvie Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Abbvie Inc. (ticker: ABBV) is a publicly traded company based in the United States, with a market capitalization of approximately $458.24 billion. The company is involved in the biopharmaceutical industry, focusing on the development and commercialization of innovative therapies. Abbvie aims to address complex health challenges and improve patient outcomes through its diverse portfolio of products.